-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Focus on Chemical Machinery and Equipment Network ] Vaccines are currently recognized as one of the effective methods for preventing infectious diseases.
In recent years, with the continuous enrichment of vaccine varieties and the continuous improvement of their The size of the vaccine market has begun to rise
.
Statistics show that the size of China's vaccine market has increased from 24 billion yuan to 42.
5 billion yuan from 2016 to 2019
.
Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipmentIn recent years, with the continuous enrichment of vaccine varieties and the continuous improvement of their The size of the vaccine market has begun to rise
.
Statistics show that the size of China's vaccine market has increased from 24 billion yuan to 42.
5 billion yuan from 2016 to 2019
.
However, although China's vaccine market is huge, compared with foreign countries such as the United States, the development of the vaccine industry still has huge room for development
.
It is worth mentioning that in order to further support the development of the vaccine industry and ensure the supply of vaccines
.
The country has issued a series of policies and regulations in recent years to promote the development of this industry
.
On December 11, 2020, the State Administration of Municipal Supervision announced the "Administrative Measures for the Batch Issuance of Biological Products", which further improved the management measures for the determination of the batch issuance of biological products, the application for batch issuance, and the review and inspection of biological products
.
.
It is worth mentioning that in order to further support the development of the vaccine industry and ensure the supply of vaccines
.
The country has issued a series of policies and regulations in recent years to promote the development of this industry
.
On December 11, 2020, the State Administration of Municipal Supervision announced the "Administrative Measures for the Batch Issuance of Biological Products", which further improved the management measures for the determination of the batch issuance of biological products, the application for batch issuance, and the review and inspection of biological products
.
With the formal implementation of the Measures on March 1, 2021, the industry believes that the batch issuance of biological products in China has entered a more standardized stage, and the future development space will also be more substantial
.
Forecasts show that according to the development trend of the domestic vaccine industry, China's vaccine market will continue to maintain rapid growth in the future, and it will exceed 60 billion yuan in 2021
.
.
Forecasts show that according to the development trend of the domestic vaccine industry, China's vaccine market will continue to maintain rapid growth in the future, and it will exceed 60 billion yuan in 2021
.
As the vaccine market continues to expand, some analysts said that because vaccines will accelerate their production expansion in the process of commercialization, the industry's demand for vaccine production and packaging equipment is also expected to increase
.
It is understood that the production of vaccines generally requires fermentation, collection/inactivation, processing, preparation, and filling.
The main nodes are configuration and filling.
Considering the safety and quality of vaccines, vaccine companies are therefore As the demand for manufacturing and filling equipment increases, the requirements will also become higher
.
.
It is understood that the production of vaccines generally requires fermentation, collection/inactivation, processing, preparation, and filling.
The main nodes are configuration and filling.
Considering the safety and quality of vaccines, vaccine companies are therefore As the demand for manufacturing and filling equipment increases, the requirements will also become higher
.
In addition, the safety requirements of vaccines have always been higher than those of general medicines
.
Therefore, in this context, vaccine companies also need more cutting-edge, efficient and safe pharmaceutical equipment to help the further development of the vaccine industry
.
According to the author's understanding, in fact, many pharmaceutical equipment companies have begun to transform and innovate equipment for vaccine research and development, production, and storage to help the further development of the vaccine industry
.
Pharmaceutical equipment.
Therefore, in this context, vaccine companies also need more cutting-edge, efficient and safe pharmaceutical equipment to help the further development of the vaccine industry
.
According to the author's understanding, in fact, many pharmaceutical equipment companies have begun to transform and innovate equipment for vaccine research and development, production, and storage to help the further development of the vaccine industry
.
For example, in the research and development process, because the research and development of vaccines and biological drugs are under great pressure, how to speed up the efficiency in the complicated and long research and development process, reduce costs and ensure the safety and stability of products is very important
.
To this end, there are pharmaceutical equipment companies that provide a complete set of bioprocess solutions for domestic and foreign biopharmaceutical companies
.
From a hardware point of view, this process for the production of vaccine products developed disposable bio- reactors , equipment, supplies, to provide sophisticated technology
.
From the perspective of software, there is also a dedicated process analysis and control platform, with data and algorithms as the basis
.
reactor.
To this end, there are pharmaceutical equipment companies that provide a complete set of bioprocess solutions for domestic and foreign biopharmaceutical companies
.
From a hardware point of view, this process for the production of vaccine products developed disposable bio- reactors , equipment, supplies, to provide sophisticated technology
.
From the perspective of software, there is also a dedicated process analysis and control platform, with data and algorithms as the basis
.
Generally speaking, as China's vaccine industry enters a stage of rapid development, pharmaceutical equipment will also usher in more opportunities
.
However, it should be noted that in the field of high-end vaccine manufacturing and filling equipment, China is still dominated by imported equipment, and there are only a few domestic companies that can provide high-end vaccine manufacturing and filling equipment
.
Therefore, for domestic pharmaceutical equipment companies, in the future, it is necessary to continuously improve the technology, intelligence, and automation level of products to accelerate the promotion of import substitution of products
.
.
However, it should be noted that in the field of high-end vaccine manufacturing and filling equipment, China is still dominated by imported equipment, and there are only a few domestic companies that can provide high-end vaccine manufacturing and filling equipment
.
Therefore, for domestic pharmaceutical equipment companies, in the future, it is necessary to continuously improve the technology, intelligence, and automation level of products to accelerate the promotion of import substitution of products
.
Of course, in addition, in the future to further ensure vaccine safety, pharmaceutical equipment companies must also strive to ensure that the data of vaccines and other drugs in the production process and inspection process are true, complete, reliable, and traceable
.
.
Original title: my country's vaccine industry has entered a stage of rapid development, and the pharmaceutical machinery industry will usher in opportunities and challenges
